Enantiomerically pure atomoxetine and tomoxetine mandelate
    31.
    发明申请
    Enantiomerically pure atomoxetine and tomoxetine mandelate 失效
    对映异构纯的阿托西汀和托莫西汀扁桃酸酯

    公开(公告)号:US20060009490A1

    公开(公告)日:2006-01-12

    申请号:US11170378

    申请日:2005-06-28

    IPC分类号: A61K31/47

    摘要: The present invention provides enantiomerically pure (R)-(−)-tomoxetine (S)-(+)-mandelate and atomoxetine HCl. The present invention further provides enantiomerically pure (R)-(−)-tomoxetine (S)-(+)-mandelate prepared from racemic tomoxetine. The present invention also provides enantiomerically pure atomoxetine HCl prepared from (R)-(−)-tomoxetine (S)-(+)-mandelate.

    摘要翻译: 本发明提供对映体纯的(R) - ( - ) - 托莫西汀(S) - (+) - 扁桃酸酯和阿托西汀HCl。 本发明还提供由外消旋的托莫西汀制备的对映体纯的(R) - ( - ) - 托莫西汀(S) - (+) - 扁桃酸酯。 本发明还提供由(R) - ( - ) - 托莫西汀(S) - (+) - 扁桃酸酯制备的对映体纯的阿托莫西汀HCl。

    Enantiomerically pure atomoxetine and tomoxetine mandelate
    32.
    发明授权
    Enantiomerically pure atomoxetine and tomoxetine mandelate 失效
    对映异构纯的阿托西汀和托莫西汀扁桃酸酯

    公开(公告)号:US07439398B2

    公开(公告)日:2008-10-21

    申请号:US11170378

    申请日:2005-06-28

    摘要: The present invention provides enantiomerically pure (R)-(−)-tomoxetine (S)-(+)-mandelate and atomoxetine HCl. The present invention further provides enantiomerically pure (R)-(−)-tomoxetine (S)-(+)-mandelate prepared from racemic tomoxetine. The present invention also provides enantiomerically pure atomoxetine HCl prepared from (R)-(−)-tomoxetine (S)-(+)-mandelate.

    摘要翻译: 本发明提供对映体纯的(R) - ( - ) - 托莫西汀(S) - (+) - 扁桃酸酯和阿托西汀HCl。 本发明还提供由外消旋的托莫西汀制备的对映体纯的(R) - ( - ) - 托莫西汀(S) - (+) - 扁桃酸酯。 本发明还提供由(R) - ( - ) - 托莫西汀(S) - (+) - 扁桃酸酯制备的对映体纯的阿托莫西汀HCl。